A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung.

PURPOSE Single photon emission computed tomography (SPECT) provides a map of the spatial distribution of lung perfusion. Thus, SPECT guidance can be used to divert dose away from higher-functioning lung, potentially reducing lung toxicity. We present a methodology for achieving this aim and test it in intensity-modulated radiotherapy (IMRT) treatment-planning. METHODS AND MATERIALS IMRT treatment plans were generated with and without SPECT guidance and compared for 5 patients. Healthy lung was segmented into four regions on the basis of SPECT intensity in the SPECT plan. Dose was sequentially allowed to the target via regions of increasing SPECT intensity. This process results in reduction of dose to functional lung, reflected in the dose-function histogram (DFH). The plans were compared using DFHs and F(20)/F(30) values (F(x) is the functional lung receiving dose above x Gy). RESULTS In all cases, the SPECT-guided plan produced a more favorable DFH compared with the non-SPECT-guided plan. Additionally, the F(20) and F(30) values were reduced for all patients by an average of 13.6% +/- 5.2% and 10.5% +/- 5.8%, respectively. In all patients, DFHs of the two highest-functioning SPECT regions were reduced, whereas DFHs of the two lower-functioning regions were increased, illustrating the dose "give-take" between SPECT regions during redistribution. CONCLUSIONS SPECT-guided IMRT shows potential for reducing the dose delivered to highly functional lung regions. This dose reduction could reduce the number of high-grade pneumonitis cases that develop after radiation treatment and improve patient quality of life.

[1]  Ronald J. Jaszczak,et al.  SPECT Quantification of Technetium‐99m Microspheres Within the Canine Lung , 1985, Journal of computer assisted tomography.

[2]  Thomas Guerrero,et al.  Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[3]  A L Boyer,et al.  Intensity-modulated radiation therapy with dynamic multileaf collimators. , 1999, Seminars in radiation oncology.

[4]  S. Kristersson,et al.  Prediction of pulmonary function loss due to pneumonectomy using 133 Xe-radiospirometry. , 1972, Chest.

[5]  David Pérol,et al.  A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  L B Marks,et al.  The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. , 1995, International journal of radiation oncology, biology, physics.

[7]  T G Turkington,et al.  Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. , 1999, Lung cancer.

[8]  Joos V Lebesque,et al.  Optimizing radiation treatment plans for lung cancer using lung perfusion information. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Andrew Jackson,et al.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.

[10]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[11]  L. Ketai,et al.  Potential uses of computed tomography-SPECT and computed tomography-coincidence fusion images of the chest. , 2001, Clinical nuclear medicine.

[12]  Masahiro Endo,et al.  Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. , 2003, International journal of radiation oncology, biology, physics.

[13]  A H Baydush,et al.  Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. , 2004, Medical physics.

[14]  R. Jaszczak,et al.  In vivo regional quantitation of intrathoracic Tc-99m using SPECT: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[16]  Frederic Courbon,et al.  The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  A. Klumper,et al.  Dual isotope (81Krm and 99Tcm) SPECT in lung function diagnosis. , 1986, Physics in medicine and biology.

[18]  G. Ceresoli,et al.  Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Joos V Lebesque,et al.  Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[21]  T. Piotrowski,et al.  Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. , 2005, Neoplasma.

[22]  J. Smith,et al.  Lung cancer in patients with borderline lung functions--zonal lung perfusion scans at presentation and lung function after high dose irradiation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  W. Bria,et al.  Prediction of postoperative pulmonary function following thoracic operations. Value of ventilation-perfusion scanning. , 1983, The Journal of thoracic and cardiovascular surgery.

[24]  I. Toro,et al.  The use of SPECT in preoperative assessment of patients with lung cancer , 2004, European Respiratory Journal.

[25]  P. Kirchner,et al.  Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. , 1980, The Journal of thoracic and cardiovascular surgery.

[26]  Andrew Jackson,et al.  Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[27]  Radhe Mohan,et al.  Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[28]  G. Tracton,et al.  Image registration: an essential part of radiation therapy treatment planning. , 1998, International journal of radiation oncology, biology, physics.

[29]  M T Munley,et al.  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[30]  R. Fisher,et al.  Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. , 2005, International Journal of Radiation Oncology, Biology, Physics.

[31]  M T Munley,et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.

[32]  K. Suga,et al.  Clinical utility of co-registered respiratory-gated 99mTc-Technegas/MAA SPECT-CT images in the assessment of regional lung functional impairment in patients with lung cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  M T Munley,et al.  Incorporation of functional status into dose-volume analysis. , 1999, Medical physics.

[34]  R. Clough,et al.  Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. , 2001, International journal of radiation oncology, biology, physics.